Compound Summary
Compound Information
acetohexamide
Compound Name: | acetohexamide |
Compound CID: | 1989 |
Synonyms: | acetohexamide 968-81-0 Dymelor Acetohexamid Gamadiabet More... |
Iupac Name: | 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea |
InChI: | InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19) |
InChIKey: | VGZSUPCWNCWDAN-UHFFFAOYSA-N |
Canonical Smiles: | CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2 |
Isomeric Smiles: | CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2 |
Molecular Weight: | 324.4 |
Molecular Formula: | C15H20N2O4S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
acetohexamide
Molecular Weight: | 324.4 |
Molecular Formula: | C15H20N2O4S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 22 |
Complexity: | 498 |
Synonyms
acetohexamide
| acetohexamide | acetohexamide |
|---|---|
acetohexamide |
968-81-0 |
Dymelor |
Acetohexamid |
Gamadiabet |
Dimelor |
Hypoglicil |
Metaglucina |
Tsiklamid |
Dimelin |
Minoral |
Ordimel |
Acetohexamida |
Acetohexamidum |
1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea |
N-(p-Acetylphenylsulfonyl)-N-cyclohexylurea |
1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea |
NCI-C03247 |
UNII-QGC8W08I6I |
1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea |
4-Acetyl-N-(cyclohexylamino)carbonylbenzenesulfonamide |
Benzenesulfonamide, 4-acetyl-N-(cyclohexylamino)carbonyl- |
U-14812 |
4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide |
QGC8W08I6I |
Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)- |
3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea |
CHEBI:28052 |
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide |
DSSTox_CID_7 |
NCGC00015014-05 |
CAS-968-81-0 |
1-(p-Acetylphenyl)sulfonyl-3-cyclohexylurea |
DSSTox_RID_75319 |
DSSTox_GSID_20007 |
Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl- |
Urea, 1-(p-acetylphenyl)sulfonyl-3-cyclohexyl- |
Acetohexamidum INN-Latin |
Acetohexamida INN-Spanish |
CCRIS 4 |
Dymelor (TN) |
1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea |
HSDB 3280 |
SR-01000075539 |
EINECS 213-530-4 |
U 14812 |
BRN 2225115 |
N-(p-Acetylbenzenesulfonyl)-N-cyclohexylurea |
Prestwick_3 |
3-aminomethylbenzamide |
Acetohexamide USAN) |
4-Acetyl-N-(cyclohexylamino)-carbonylbenzenesulfonamide |
Acetohexamide USAN:USP:INN:BAN:JAN |
Lopac-A-178 |
Prestwick0_000055 |
Prestwick1_000055 |
Prestwick2_000055 |
Prestwick3_000055 |
A-178 |
CHEMBL1589 |
Lopac0_000088 |
SCHEMBL37620 |
BSPBio_000209 |
MLS002154186 |
SPBio_002130 |
4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide |
BPBio1_000231 |
GTPL6793 |
DTXSID7020007 |
Acetohexamide (JP17/USP/INN) |
Acetohexamide, analytical standard |
HMS1568K11 |
HMS2093H21 |
HMS2095K11 |
HMS2236M07 |
HMS3260A18 |
HMS3372B02 |
HMS3712K11 |
Pharmakon1600-01505425 |
BCP34666 |
HY-B0881 |
Tox21_110067 |
Tox21_202022 |
Tox21_302735 |
Tox21_500088 |
MFCD00072156 |
NSC759128 |
s5717 |
ZINC18067894 |
AKOS015916290 |
Tox21_110067_1 |
CCG-204183 |
DB00414 |
LP00088 |
MCULE-3744173137 |
NSC 759128 |
NSC-759128 |
SDCCGSBI-0050076.P003 |
VZ31185 |
NCGC00015014-01 |
NCGC00015014-02 |
NCGC00015014-03 |
NCGC00015014-04 |
NCGC00015014-06 |
NCGC00015014-07 |
NCGC00015014-08 |
NCGC00015014-11 |
NCGC00015014-15 |
NCGC00016555-01 |
NCGC00091230-01 |
NCGC00091230-02 |
NCGC00091230-03 |
NCGC00091230-04 |
NCGC00256467-01 |
NCGC00259571-01 |
NCGC00260773-01 |
SMR001233477 |
SBI-0050076.P002 |
DB-057652 |
EU-0100088 |
FT-0661053 |
C06806 |
D00219 |
1-(4-acetylbenzene)sulfonyl-3-cyclohexylurea |
A845651 |
A935756 |
Dymelor; Gamadiabet; Acetohexamid; Dimelin; Dimelor |
Q4673274 |
SR-01000075539-1 |
SR-01000075539-3 |
SR-01000075539-6 |
BRD-K52960356-001-03-1 |
BRD-K52960356-001-06-4 |
Z1558572527 |
1-Acetyl-4-(((cyclohexylamino)carbonylamino)sulfonyl)benzene # |
Acetohexamide, United States Pharmacopeia (USP) Reference Standard |
1-(4-acetylbenzene)sulfonyl-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide |
Experimental Data
acetohexamide
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 0 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
acetohexamide
Statistics Data
acetohexamide
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0 | 1 | 1 |
Statistics Data Visualization
acetohexamide
